Rep. Murphy, Colleagues Introduce Bill to Expedite Substitution Process for Pharmaceuticals, Lower Drug Prices
September 20, 2022
September 20, 2022
WASHINGTON, Sept. 20 -- Rep. Gregory Murphy, R-North Carolina, issued the following news release:
Reps. Greg Murphy, M.D. (NC-03), Mariannette Miller-Meeks (IA-02), Nanette Barragan (CA-44), and Ann Kuster (D-NH) introduced the bipartisan Biologics Competition Act to direct the Secretary of Health and Human Services to evaluate the process by which interchangeable biological products are approved to be used in pharmaceuticals. In many cases, these interchangeable products are more a . . .
Reps. Greg Murphy, M.D. (NC-03), Mariannette Miller-Meeks (IA-02), Nanette Barragan (CA-44), and Ann Kuster (D-NH) introduced the bipartisan Biologics Competition Act to direct the Secretary of Health and Human Services to evaluate the process by which interchangeable biological products are approved to be used in pharmaceuticals. In many cases, these interchangeable products are more a . . .